In vitro anti-Plasmodial activity screening facility
New treatments against the drug-resistant Plasmodium parasite are urgently needed. Candidates must be effective at low concentrations, be safe to give to children and pregnant women, inexpensive, highly stable, have a novel mode of action and preferably be administered orally. A new anti-malarial candidate is tested in vitro against the malaria parasite. Parasite proliferation is examined through detection and monitoring of DNA replication.
At M2PL we provide the following services:
For more information contact:
Prof Lyn-Marie Birkholtz [Email]
Mrs. Janette Reader [Email]
Copyright © University of Pretoria 2024. All rights reserved.
Get Social With Us
Download the UP Mobile App